• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Value of anti-VEGF treatment in choroidal neovascularization associated with autosomal recessive bestrophinopathy.抗VEGF治疗在常染色体隐性遗传性Bestrophin病相关性脉络膜新生血管中的价值
Digit J Ophthalmol. 2013 Dec 30;19(4):59-63. doi: 10.5693/djo.02.2013.09.001. eCollection 2013.
2
Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.贝伐单抗(阿瓦斯汀)治疗年龄相关性黄斑变性和脉络膜新生血管的色素上皮脱离的预后意义。
Retina. 2011 Oct;31(9):1812-8. doi: 10.1097/IAE.0b013e31821987a4.
3
Intravitreal ranibizumab and bevacizumab therapy for choroidal neovascularization in age-related macular degeneration with extensive pre-existing geographic atrophy.玻璃体内注射雷珠单抗和贝伐单抗治疗年龄相关性黄斑变性伴广泛预先存在的地图样萎缩的脉络膜新生血管。
Arq Bras Oftalmol. 2012 Jul-Aug;75(4):273-6. doi: 10.1590/s0004-27492012000400011.
4
Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.年龄相关性黄斑变性中的血管化视网膜色素上皮脱离:治疗和 RPE 撕裂发生率。
Graefes Arch Clin Exp Ophthalmol. 2012 Sep;250(9):1283-92. doi: 10.1007/s00417-012-1955-2. Epub 2012 Feb 21.
5
Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.年龄相关性黄斑变性中抗血管内皮生长因子治疗后脉络膜新生血管类型与眼底自发荧光的变化
Korean J Ophthalmol. 2016 Feb;30(1):17-24. doi: 10.3341/kjo.2016.30.1.17. Epub 2016 Jan 21.
6
Intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration.玻璃体内注射雷珠单抗和贝伐单抗治疗年龄相关性黄斑变性中非中心凹脉络膜新生血管
Arq Bras Oftalmol. 2009 Sep-Oct;72(5):677-81. doi: 10.1590/s0004-27492009000500016.
7
Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.年龄相关性黄斑变性治疗试验比较第二年的黄斑形态与视力
Ophthalmology. 2016 Apr;123(4):865-75. doi: 10.1016/j.ophtha.2015.12.002. Epub 2016 Jan 9.
8
Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.频域光相干断层扫描揭示玻璃体内抗血管内皮生长因子治疗后视网膜色素上皮撕裂的形成机制。
Am J Ophthalmol. 2013 Nov;156(5):981-988.e2. doi: 10.1016/j.ajo.2013.06.024. Epub 2013 Aug 20.
9
Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.玻璃体内注射贝伐单抗治疗年龄相关性黄斑变性先前治疗过的脉络膜新生血管。
Retina. 2007 Apr-May;27(4):432-8. doi: 10.1097/IAE.0b013e318042b53f.
10
Use of Intravitreal Bevacizumab in a 9-Year-Old Child with Choroidal Neovascularization Associated with Autosomal Recessive Bestrophinopathy.玻璃体内注射贝伐单抗治疗一名9岁患有与常染色体隐性遗传性Bestrophinopathy相关的脉络膜新生血管的儿童。
Ophthalmic Genet. 2015;36(3):265-9. doi: 10.3109/13816810.2014.962706.

引用本文的文献

1
Clinical outcomes of treated macular neovascularisation secondary to inherited retinal diseases: a literature review.治疗遗传性视网膜疾病所致黄斑新生血管的临床结局:文献综述。
BMJ Open Ophthalmol. 2023 Jul;8(1). doi: 10.1136/bmjophth-2023-001309.
2
Bilateral Choroidal Neovascularization and Chorioretinal Anastomosis in Autosomal Recessive Bestrophinopathy.常染色体隐性遗传性Bestrophin病中的双侧脉络膜新生血管形成及脉络膜视网膜吻合
J Vitreoretin Dis. 2019 Oct 17;4(1):69-74. doi: 10.1177/2474126419880383. eCollection 2020 Jan-Feb.
3
ANATOMICAL AND FUNCTIONAL OUTCOMES OF BEVACIZUMAB TREATMENT IN PEDIATRIC AUTOSOMAL RECESSIVE BESTROPHINOPATHY.贝伐单抗治疗小儿常染色体隐性遗传性Bestrophinopathy的解剖学和功能学结果
Retin Cases Brief Rep. 2024 May 1;18(3):378-386. doi: 10.1097/ICB.0000000000001390. Epub 2023 Dec 7.
4
Diffuse Outer Layer Opacification: A Novel Finding in Patients With Autosomal Recessive Bestrophinopathy.弥漫性外层视网膜混浊:常染色体隐性遗传性 Bestrophinopathy 患者的一种新发现。
Asia Pac J Ophthalmol (Phila). 2019 Nov-Dec;8(6):469-475. doi: 10.1097/APO.0000000000000261.
5
Ten-Year Follow-Up after Bilateral Submacular Neovascular Membrane Removal in a Case of Autosomal Recessive Bestrophinopathy.常染色体隐性遗传性Bestrophin病患者双侧黄斑下新生血管膜切除术后十年随访
Case Rep Ophthalmol. 2017 Apr 24;8(1):265-270. doi: 10.1159/000473696. eCollection 2017 Jan-Apr.

本文引用的文献

1
How the comparison of age-related macular degeneration treatments trial results will impact clinical care.年龄相关性黄斑变性治疗比较试验结果将如何影响临床护理。
Am J Ophthalmol. 2011 Oct;152(4):509-14. doi: 10.1016/j.ajo.2011.07.004.
2
Autosomal recessive best vitelliform macular dystrophy: report of a family and management of early-onset neovascular complications.常染色体隐性遗传性最佳型卵黄样黄斑营养不良:一家系报告及早发性新生血管并发症的处理
Arch Ophthalmol. 2011 Feb;129(2):211-7. doi: 10.1001/archophthalmol.2010.367.
3
Bestrophins and retinopathies.Bestrophins 与视网膜病变。
Pflugers Arch. 2010 Jul;460(2):559-69. doi: 10.1007/s00424-010-0821-5. Epub 2010 Mar 28.
4
Detailed analysis of retinal function and morphology in a patient with autosomal recessive bestrophinopathy (ARB).常染色体隐性遗传性Bestrophin病(ARB)患者视网膜功能和形态的详细分析。
Doc Ophthalmol. 2009 Jun;118(3):239-46. doi: 10.1007/s10633-008-9154-5. Epub 2008 Nov 5.
5
Biallelic mutation of BEST1 causes a distinct retinopathy in humans.BEST1基因的双等位基因突变会导致人类出现一种独特的视网膜病变。
Am J Hum Genet. 2008 Jan;82(1):19-31. doi: 10.1016/j.ajhg.2007.08.004.
6
Ca2+ channels in retinal pigment epithelial cells regulate vascular endothelial growth factor secretion rates in health and disease.视网膜色素上皮细胞中的钙离子通道在健康和疾病状态下调节血管内皮生长因子的分泌速率。
Mol Vis. 2007 Mar 27;13:443-56.
7
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.一项采用光学相干断层扫描引导的、玻璃体腔内注射雷珠单抗(Lucentis)可变给药方案治疗新生血管性年龄相关性黄斑变性的研究。
Am J Ophthalmol. 2007 Apr;143(4):566-83. doi: 10.1016/j.ajo.2007.01.028.

抗VEGF治疗在常染色体隐性遗传性Bestrophin病相关性脉络膜新生血管中的价值

Value of anti-VEGF treatment in choroidal neovascularization associated with autosomal recessive bestrophinopathy.

作者信息

Madhusudhan Savitha, Hussain Ahsen, Sahni Jayashree N

机构信息

St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom.

出版信息

Digit J Ophthalmol. 2013 Dec 30;19(4):59-63. doi: 10.5693/djo.02.2013.09.001. eCollection 2013.

DOI:10.5693/djo.02.2013.09.001
PMID:24459458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3899805/
Abstract

A 26-year-old white woman presented with a 1-year history of reduced vision in both eyes, bilateral yellowish deposits in the central macula, and pale yellow retinal flecks extending to midretinal periphery. Choroidal neovascularization (CNV) was confirmed in her left eye. On optical coherence tomography, both eyes showed diffuse intraretinal cystic spaces, thickening and separation of the photoreceptor layer from the retinal pigment epithelium (RPE), subretinal fluid, and focal thickening at the level of the RPE at the fovea. A diagnosis of autosomal recessive bestrophinopathy was confirmed by electrodiagnostic and molecular genetics testing. The CNV responded well to intravitreal ranibizumab therapy, and visual acuity in the left eye improved and stabilized; however, retinoschisis due to fluctuations in intraretinal fluid persisted. This case highlights the fact that current optical coherence tomography-driven protocols used widely to treat neovascular age-related macular degeneration may not be appropriate for CNV associated with other retinal diseases.

摘要

一名26岁的白人女性,双眼视力下降1年,中央黄斑区有双侧淡黄色沉积物,淡黄色视网膜斑点延伸至视网膜中周部。左眼确诊为脉络膜新生血管(CNV)。光学相干断层扫描显示,双眼均有弥漫性视网膜内囊样间隙、光感受器层与视网膜色素上皮(RPE)增厚及分离、视网膜下液,以及黄斑区RPE水平的局灶性增厚。电诊断和分子遗传学检测确诊为常染色体隐性遗传性Bestrophin病。CNV对玻璃体内注射雷珠单抗治疗反应良好,左眼视力改善并稳定;然而,由于视网膜内液波动导致的视网膜劈裂持续存在。该病例突出了一个事实,即目前广泛用于治疗新生血管性年龄相关性黄斑变性的光学相干断层扫描驱动方案可能不适用于与其他视网膜疾病相关的CNV。